Evidence map›Paper›PMID 10991875›Full record

ArticleAntimicrobial agents and chemotherapy2000

Efficacy of voriconazole in a guinea pig model of disseminated invasive aspergillosis.

W R Kirkpatrick, R K McAtee, A W Fothergill, M G Rinaldi, T F Patterson

Open access · greenAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
5.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 79 citations in OpenAlex.

  1. Trial
  2. Studies in mycology · 2021
    Review
  3. Article
  4. Article
  5. Animal Models of Aspergillosis.Comparative medicine · 2018
    Review
  6. Article
  7. Rodent Models of Invasive Aspergillosis due toFrontiers in microbiology · 2017
    Review
  8. Article
  9. Management of invasive aspergillosis in patients with COPD: rational use of voriconazole.International journal of chronic obstructive pulmonary disease · 2009
    Review
  10. Article
  11. Review
  12. Article
  13. New guinea pig model of Cryptococcal meningitis.Antimicrobial agents and chemotherapy · 2007
    Article
  14. Voriconazole in the management of nosocomial invasive fungal infections.Therapeutics and clinical risk management · 2006
    Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

W R KirkpatrickDepartments of Medicine, The University of Texas Health Science Center at San Antonio, San Antonio, Texas 78229-3900, USA. KIRKPATRICK@UTHSCSA.EDU
R K McAtee
A W Fothergill
M G Rinaldi
T F Patterson
Murphy Oil Corporation (United States) · USSouth Texas Veterans Health Care System · USThe University of Texas Health Science Center at San Antonio · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Voriconazole (VRC) was evaluated in an immunosuppressed-guinea pig model of invasive aspergillosis. VRC was more effective than amphotericin B or similar doses of itraconazole in the clearance of Aspergillus from tissues. VRC treatment regimens improved survival and significantly reduced tissue colony counts compared with those of controls.

Indexed as

Amphotericin BAnimalsAntifungal AgentsAspergillosisAspergillus fumigatusFluocinolone AcetonideGlucocorticoidsGuinea PigsImmunocompromised HostImmunosuppressive AgentsMaleOrgan Culture TechniquesPyrimidinesTriazolesVoriconazoleAmphotericin BAntifungal AgentsFluocinolone AcetonideGlucocorticoidsImmunosuppressive AgentsPyrimidinesTriazolesVoriconazole

Identifiers

PMID10991875
PMCPMC90166
OpenAlexW2097381055

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.